EUROPE DNA SEQUENCING MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE DNA SEQUENCING MARKET 2021-2028

Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s research on the European DNA sequencing market shows that it will develop with a CAGR of 17.41% in terms of revenue during the forecast years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries considered in this market are:

•           The United Kingdom

•           Russia

•           France

•           Germany

•           Spain

•           Italy

•           Rest of Europe countries

With the growing prevalence of diseases, Germany has invested significantly in the field of healthcare and medical research. This is expected to drive the growth of the German market. According to the OECD, the country spent nearly 3.1% of its GDP on research and development activities. These investments have fostered the growth of the nation’s healthcare sector exponentially.

Biotechnology and pharmaceutical companies in the country are making huge investments in the area of personalized medicine, which is largely reliant on technologies such as next-generation sequencing. It is expected that advanced technologies will be available in hospitals and healthcare facilities in the course of the next few years. In March 2018, it was reported that the German Research Foundation (DFG) funded four new sequencing centers in the country, with a total funding of $ 17.3 million. These factors are expected to propel the growth of the German market.

On the other hand, the market in France is also witnessing increased growth, thanks to the rising expenditure on healthcare and a rise in the prevalence of diseases. The expenditure on R&D activities is also expected to grow substantially over the forecasting phase, which may further fuel the studied market. According to the OECD, the total R&D spending by the country in 2018 amounted to 2.1% of the national gross domestic product. Besides, the rise in government initiatives has also augmented the development of the French market. For instance, in 2015, the government commissioned the French Plan for Genomic Medicine 2025, with an investment of about EUR 650 million over the first five years.

F Hoffmann-La Roche Ltd (Roche) is a healthcare company engaged in the development and commercialization of innovative diagnostic and therapeutic products. It manufactures pharmaceutical products in various therapeutic areas, such as immunology, oncology, ophthalmology, neuroscience, and infectious diseases. The company also offers clinical chemistry, immunoassays, laboratory automation & IT solutions, hematology & hemostasis products, patient urinalysis products, and self-testing products. Roche provides its products and services to commercial hospitals, diagnostic laboratories, researchers, pharmacists, and healthcare professionals. It is headquartered in Basel, Switzerland.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE DNA SEQUENCING MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE DNA SEQUENCING MARKET

2.2. KEY INSIGHTS

2.2.1. APPLICATIONS OF LIQUID BIOPSY

2.2.2. DEVELOPMENT IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY

2.2.3. NEXT GENERATION SEQUENCING

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. INDUSTRY COMPONENTS

2.5. KEY IMPACT ANALYSIS

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. KEY MARKET STRATEGIES

2.8.1. CONTRACTS AND PARTNERSHIPS

2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

2.8.3. ACQUISITIONS & MERGERS

2.8.4. NEW PRODUCT LAUNCHES

2.9. MARKET DRIVERS

2.9.1. PREVALENCE OF CANCER CASES

2.9.2. ADVANCEMENTS IN TECHNOLOGY

2.9.3. APPLICATIONS OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION

2.10. MARKET RESTRAINTS

2.10.1. CHALLENGES ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS

2.10.2. LIMITATIONS OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING

2.11. MARKET OPPORTUNITIES

2.11.1. EXTENSIVE RESEARCH AND DEVELOPMENT IN DNA SEQUENCING

2.11.2. GROWTH IN GENOME MAPPING PROGRAMS

3. EUROPE DNA SEQUENCING MARKET – BY PRODUCT

3.1. INSTRUMENTS & CONSUMABLES

3.1.1. INSTRUMENTS & CONSUMABLES TYPE

3.1.1.1. CONSUMABLES

3.1.1.2. INSTRUMENTS

3.1.2.   INSTRUMENTS & CONSUMABLES PLATFORM

3.1.2.1. NGS (NEXT GENERATION SEQUENCING)

3.1.2.1.1. RNA SEQUENCING

3.1.2.1.2. TARGETED RESEQUENCING

3.1.2.1.3. WHOLE-EXOME SEQUENCING

3.1.2.1.4. WHOLE-GENOME SEQUENCING

3.1.2.1.5. CHIP SEQUENCING

3.1.2.1.6. DE NOVO SEQUENCING

3.1.2.1.7. METHYL SEQUENCING

3.1.2.2. SANGER

3.2. SEQUENCING SERVICES

3.3. BIOINFORMATICS

4. EUROPE DNA SEQUENCING MARKET – BY TECHNOLOGY

4.1. SEQUENCING BY SYNTHESIS

4.2. ION SEMICONDUCTOR SEQUENCING

4.3. CHAIN TERMINATION SEQUENCING

4.4. PYROSEQUENCING

4.5. SEQUENCING BY LIGATION (SBL)

4.6. SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)

4.7. NANOPORE SEQUENCING

4.8. OTHER TECHNOLOGIES

5. EUROPE DNA SEQUENCING MARKET – BY APPLICATION

5.1. BIOMARKER DISCOVERY

5.2. DIAGNOSTICS

5.3. REPRODUCTIVE HEALTH

5.4. PERSONALIZED MEDICINE

5.5. DRUG DISCOVERY

5.6. AGRICULTURE & ANIMAL RESEARCH

5.7. FORENSICS

5.8. OTHER APPLICATIONS

6. EUROPE DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS

6.1. RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES

6.2. PHARMACEUTICAL

6.3. BIOTECHNOLOGY COMPANIES

6.4. HOSPITALS & CLINICS

6.5. OTHER INDUSTRY VERTICALS

7. EUROPE DNA SEQUENCING MARKET – COUNTRY OUTLOOK

7.1. GERMANY

7.2. FRANCE

7.3. THE UNITED KINGDOM

7.4. ITALY

7.5. RUSSIA

7.6. SPAIN

7.7. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

8.1. ADAPTIVE BIOTECHNOLOGIES INC

8.2. AGILENT TECHNOLOGIES INC

8.3. ASURAGEN INC

8.4. BGI GENOMICS

8.5. BIO-RAD LABORATORIES INC

8.6. DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)

8.7. EUROFINS SCIENTIFIC

8.8. F HOFFMANN-LA ROCHE

8.9. ILLUMINA INC

8.10. MERCK KGAA

8.11. PACIFIC BIOSCIENCES OF CALIFORNIA INC

8.12. PERKINELMER INC

8.13. SIEMENS HEALTHINEERS AG

8.14. SPIRAL GENETICS INC

8.15. THERMO FISHER SCIENTIFIC INC

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1. OBJECTIVES OF STUDY

9.1.2. SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1. PRIMARY DATA SOURCES

9.2.2. SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1. EVALUATION OF PROPOSED MARKET

9.3.2. IDENTIFICATION OF DATA SOURCES

9.3.3. ASSESSMENT OF MARKET DETERMINANTS

9.3.4. DATA COLLECTION

9.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       EUROPE DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       NEW PRODUCT LAUNCHES

TABLE 7:       EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 8:       EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)

TABLE 10:     EUROPE NGS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 11:     EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 12:     EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 13:     EUROPE DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 14:     EUROPE DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

FIGURE 3:     EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)

FIGURE 4:     EUROPE DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 7:     EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)

FIGURE 8:     EUROPE NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 11:  EUROPE NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 14:  EUROPE NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 15:  EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)

FIGURE 17:  EUROPE DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)

FIGURE 18:  EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 19:  EUROPE DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)

FIGURE 20:  EUROPE DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 21:  EUROPE DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 22:  EUROPE DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 23:  EUROPE DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)

FIGURE 24:  EUROPE DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)

FIGURE 25:  EUROPE DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)

FIGURE 26:  EUROPE DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 27:  EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 28:  EUROPE DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 29:  EUROPE DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 30:  EUROPE DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

FIGURE 31:  EUROPE DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

FIGURE 32:  EUROPE DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

FIGURE 33:  EUROPE DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)

FIGURE 34:  EUROPE DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)

FIGURE 35:  EUROPE DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 36:  EUROPE DNA SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 37:  EUROPE DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 38:  EUROPE DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)

FIGURE 39:  EUROPE DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 40:  EUROPE DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 41:  EUROPE DNA SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

FIGURE 42:  GERMANY DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 43:  FRANCE DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 44:  THE UNITED KINGDOM DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 45:  ITALY DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 46:  RUSSIA DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 47:  SPAIN DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

FIGURE 48:  REST OF EUROPE DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;